|
Post by rockstarrick on May 12, 2019 1:32:54 GMT -5
Y E S Bought a ton more yesterday at $1.2299 so........Y E S Can't believe I'm getting another chance to buy this low. A company with an entire delivery platform, entering 2 phase 3 trials within a year, selling an FDA approved product showing 8 quarters of QOQ and YOY growth and already selling $50 million a year is worth more than a $250 million market cap...... PERIOD Sports, isn't it interesting listening to new naïve "investors" sound just like we did years ago? Yep. No where to go but UP, right? He’s been around probably as long or longer than me. He’s no newbie. just saying 😬
|
|
|
Post by pat on May 12, 2019 6:27:02 GMT -5
Rad is right.
What exactly has changed in the past few weeks to get everyone running off a cliff like lemmings?
I’m no newbie and I continue to buy.
Breathe people.
|
|
|
Post by tayl5 on May 12, 2019 8:07:52 GMT -5
I've been a MNKD stockholder for over ten years. Other than shifting shares between accounts, I haven't sold any MannKind shares. For a few years I was an active poster, responding to most topics. That got exhausting so I became a lurker instead. For better or worse, I've read all of your posts (thanks!) and had my biases confirmed many times over. I've also lost most of my investment. That loss aside, it feels like the company (not the stock) is in better shape than it's ever been. The big worry now is the D word--dilution. For a long time, it was the B word--bankruptcy. People complain about Mike, but do you want to go back to the other guys? Maybe Al in his prime, but otherwise, hell no. I look at companies that I bailed on seven years ago that are now doing well and I think I'm an idiot. I've kept the faith with MannKind and lost my shirt, and I think I'm an idiot. But I'll be damned if I'm going to give up now and watch the company succeed without me. My takeaway is, if a company is trying to change a medical paradigm, imagine the longest time you can and add ten years. If you're not willing to wait that long, invest in tech or something. Meanwhile, I'll be here, holding my expired options and reverse-split shares, and hoping MannKind can still change the world. I'll bite. So let's be reasonable and say it takes Mannkind 5 years to really get Afrezza off the ground. Now, we add your 10 years and that brings us to fifteen years down the road. How much dilution will it take to get Mannkind that far? You're free to take off your shoes and use your toes to count if necessary.
|
|
|
Post by tayl5 on May 12, 2019 8:23:32 GMT -5
It looks like I still can't work this quote and post thing..
Replying to Falconquest, it depends on when you start the clock. Is it from when Afrezza was developed and Al started talking about it? When it was approved? Now? We could be half or most of the way through. I expected catalytic word-of-mouth to drive the scripts. Hasn't happened yet, but Mike mentioned something like that happening in the recent call.
Another point is that dilution is an illusion--you're trading shares for what should be money of equal value (sometimes it's not, but stay with me). In a reverse-split, the company valuation is initially the same. Bottom line is that what you had was just worth less than you thought it was. Maybe without those steps we'd have all the shares we bought initially and they'd be worth five cents each. That said, companies that do an r-s do tend to get hammered.
GLTA longs, especially moms. I'm back to lurking.
|
|
|
Post by rockstarrick on May 12, 2019 9:38:37 GMT -5
It looks like I still can't work this quote and post thing.. Replying to Falconquest, it depends on when you start the clock. Is it from when Afrezza was developed and Al started talking about it? When it was approved? Now? We could be half or most of the way through. I expected catalytic word-of-mouth to drive the scripts. Hasn't happened yet, but Mike mentioned something like that happening in the recent call. Another point is that dilution is an illusion--you're trading shares for what should be money of equal value (sometimes it's not, but stay with me). In a reverse-split, the company valuation is initially the same. Bottom line is that what you had was just worth less than you thought it was. Maybe without those steps we'd have all the shares we bought initially and they'd be worth five cents each. That said, companies that do an r-s do tend to get hammered. GLTA longs, especially moms. I'm back to lurking. Yes, a 100 dollar bill and 100 dollar bills are pretty much equal in value. it’s funny, if I have a 100 dollar bill, I do feel like I have more money than if I have 5 20’s, or just random bills though. 🤓
|
|
|
Post by stockwhisperer on May 12, 2019 10:06:01 GMT -5
After all these roller-coaster rides with MNKD for so many year, I am wondering how many of you are still willing to go on? Just to let everyone know, I am still on the train Have a nice weekend! I am a believer that MNKD will succeed, w/or w/o Afrezza in the lead. I think the Team has worked tirelessly to back away from the edge of the cliff MNKD was riding and that is to be commended. Were all their decisions good - like, how they got cash quickly in December. IMO, no but here we are. The things that bother me the most, aside from my money just sitting there for years w/no growth - has to do w/their behavior. I find their lack of communication & interest in SH’s beyond belief. They do not seem to realize or care that they are a public company. They seem to show the same lack of interest to the Street, which is additionally bizarre. They can give a good dog & pony show when they have to but where is the follow through - no walk to the talk. How easy is honesty & transparency. How difficult is it to just be direct, talk to SH’s - get in alignment w/us. Are they arrogant, disinterested, mad - all of these things and more? Only they know but imo, the BOD & Executive Team need to snap out of it - drop the attitude and show they care enough about SH’s, along w/the Street to repair the damage & distrust they have created. Investors want to make money. New investors - it may be easier - for old timers, well - many of us know that story. None of us can say for sure how much longer it will take for the share price to start moving up and stay up. What they are working on behind the scenes, will hopefully result in enough of a shake up to finally start bringing back some SH value. In the meantime, frustrated believer - waiting.
|
|
|
Post by falconquest on May 12, 2019 10:14:38 GMT -5
It looks like I still can't work this quote and post thing.. Replying to Falconquest, it depends on when you start the clock. Is it from when Afrezza was developed and Al started talking about it? When it was approved? Now? We could be half or most of the way through. I expected catalytic word-of-mouth to drive the scripts. Hasn't happened yet, but Mike mentioned something like that happening in the recent call. Another point is that dilution is an illusion--you're trading shares for what should be money of equal value (sometimes it's not, but stay with me). In a reverse-split, the company valuation is initially the same. Bottom line is that what you had was just worth less than you thought it was. Maybe without those steps we'd have all the shares we bought initially and they'd be worth five cents each. That said, companies that do an r-s do tend to get hammered.
GLTA longs, especially moms. I'm back to lurking. Yes, a 100 dollar bill and 100 dollar bills are pretty much equal in value. it’s funny, if I have a 100 dollar bill, I do feel like I have more money than if I have 5 20’s, or just random bills though. 🤓 tayl5, just hit the quote button, scroll down and type below the outlined box. Now to your comment, huh? I'm talking about the dilutive affect of issuing additional shares to fund ongoing operations, not reverse splits. If you own shares you own a percentage of the company (albeit a small percentage presumably) so each time new shares are issued you own an ever smaller portion of the company which means you receive an ever smaller portion of the (supposed) profits. You're right, 1000 shares at $2.00 is the same as 500 shares at $4.00 but each time new shares are issued you own a smaller percentage of the company regardless of how many shares you own or what the price is. That's no illusion!
rockstar, people have a weird relationship with money. I think they they get too emotionally wrapped up in it. holding a one hundred dollar bill, or 100, one dollar bills is all the same to me except they're both a pain in the ass because in one case you may be limited where you can use it and the other you have a big ole wad of bills to carry around. I will however, admit that I get a bit emotional about the money I lost in this investment.
|
|
|
Post by awesomo on May 12, 2019 11:04:01 GMT -5
I thought I’ve heard it all with this stock, then I just read “dilution is an illusion”...
|
|
|
Post by rockstarrick on May 12, 2019 11:25:12 GMT -5
Yes, a 100 dollar bill and 100 dollar bills are pretty much equal in value. it’s funny, if I have a 100 dollar bill, I do feel like I have more money than if I have 5 20’s, or just random bills though. 🤓 tayl5, just hit the quote button, scroll down and type below the outlined box. Now to your comment, huh? I'm talking about the dilutive affect of issuing additional shares to fund ongoing operations, not reverse splits. If you own shares you own a percentage of the company (albeit a small percentage presumably) so each time new shares are issued you own an ever smaller portion of the company which means you receive an ever smaller portion of the (supposed) profits. You're right, 1000 shares at $2.00 is the same as 500 shares at $4.00 but each time new shares are issued you own a smaller percentage of the company regardless of how many shares you own or what the price is. That's no illusion!
rockstar, people have a weird relationship with money. I think they they get too emotionally wrapped up in it. holding a one hundred dollar bill, or 100, one dollar bills is all the same to me except they're both a pain in the ass because in one case you may be limited where you can use it and the other you have a big ole wad of bills to carry around. I will however, admit that I get a bit emotional about the money I lost in this investment. Wow, commented to your response, then can’t seem to find it ?? Oh well Yes, it is a tough pill to swallow, knowing how much money I could have made if I would’ve had strict buy and sell limits, but I didn’t !! I was going for the big payday, and it could still happen. I believe I own a bigger % of the Company now than before the split, and my average is much lower that it was, so I could still make out. But the bottom line is, I owned a $hitload of mnkd, (for me anyway), @ 2.00/Share, on June 27 2014, I could’ve, and should’ve sold for a substantial profit, and then could’ve bought back in after all the smoke cleared and maybe pulled the same again. Oh hindsight is such a buzzkill !! No one to blame but me,, sure, they should run the Company in a manner that enhances shareholder value, and especially shareholders morale !! Transparency is a must, but the buy and sell trigger is all me. Ive learned many lessons that will serve me well from this mnkd journey, but not selling in 2014 is 1 mistake I wish was never made. Good Luck Everybody ✌🏻😎
|
|
|
Post by mytakeonit on May 12, 2019 11:59:22 GMT -5
Thank you mango ... and yes, I have been called a Mother before. BTW, where do you play blackjack? I love that game because it is so easy ... I have exactly 21 digits so no problem counting. And I Okay, never mind ... But, that's mytakeonit
|
|
|
Post by mytakeonit on May 12, 2019 12:09:45 GMT -5
Wow, so many people sound suicidal on Mother's Day. And, I thought you only lost $$$ if you sold your shares??? AND ... a one hundred dollar bill = 5 twenty dollar bills = 100 dollar bills = 100 Hawaii State quarters.
But, that's mytakeonit
|
|
|
Post by seanismorris on May 12, 2019 12:24:31 GMT -5
Rad is right. What exactly has changed in the past few weeks to get everyone running off a cliff like lemmings? I’m no newbie and I continue to buy. Breathe people. Something has changed, prior to the marketing campaign (TV) we were thinking “if only people knew about Afrezza” scripts would rise... Now, we realize more people know about Afrezza, having watched the TV ad, and it didn’t result in significantly more scripts. The new conclusion is, it costs more to get a new script than that script is worth. That is a BIG deal! That leaves Afrezza to grow organically... in other words there will be no big jump in scripts. We might add a few sales people, and target docs awareness through trade magazines and continue to grow scripts slowly. But, the likelihood of Afrezza becoming a blockbuster is pretty much eliminated. People have invested a ton betting on Afrezza and 95% of those investors will not make even their money back. If MNKD increases 5x from today’s price, that would still be peanuts vs what they’ve lost. If you want to bet on Techosphere that’s fine, but Afrezza needs to be written off as a niche drug. Currently, MannKind has one significant partner for Techosphere formulations (following the $$$). The milestone payments will keep MannKind afloat near term, but paying the bills isn’t good enough. The risk/reward for investing in MannKind have never been poorer. Basically, we now have clarity and that clarity is bleak... After listening to the investor call, my conclusion is the management team doesn’t believe in Afrezza. That’s not to say, they don’t believe it works but that they can’t take market share and make it pay. If they got Afrezza to 5% of mealtime patients that would be a success, 5% might be the break even point vs Afrezza related expenses... Managent is going to continue with Afrezza, they’re even going to cheer if someone sells some internationally... it keeps the production lines running at least. But, their mindset is post Afrezza. They’re asking, where is the next partner coming from to keep the doors open and their paycheck secure. That’s fine... but investors are going to get the dog and pony show, with likely even more dilution next year. Bottom line is MNKD isn’t a good investment as it lacks catalysts, but Longs aren’t going to sell (no point) and hope for a miracle instead.
|
|
|
Post by uvula on May 12, 2019 12:32:08 GMT -5
1 big disagreement with the previous poster. A niche drug is one that everyone knows about but only a few people need. And some niche drugs still make a lot of money. Afrezza isn't a niche drug, it is an unknown drug.
|
|
|
Post by seanismorris on May 12, 2019 12:45:00 GMT -5
tayl5, just hit the quote button, scroll down and type below the outlined box. Now to your comment, huh? I'm talking about the dilutive affect of issuing additional shares to fund ongoing operations, not reverse splits. If you own shares you own a percentage of the company (albeit a small percentage presumably) so each time new shares are issued you own an ever smaller portion of the company which means you receive an ever smaller portion of the (supposed) profits. You're right, 1000 shares at $2.00 is the same as 500 shares at $4.00 but each time new shares are issued you own a smaller percentage of the company regardless of how many shares you own or what the price is. That's no illusion!
rockstar, people have a weird relationship with money. I think they they get too emotionally wrapped up in it. holding a one hundred dollar bill, or 100, one dollar bills is all the same to me except they're both a pain in the ass because in one case you may be limited where you can use it and the other you have a big ole wad of bills to carry around. I will however, admit that I get a bit emotional about the money I lost in this investment. Wow, commented to your response, then can’t seem to find it ?? Oh well Yes, it is a tough pill to swallow, knowing how much money I could have made if I would’ve had strict buy and sell limits, but I didn’t !! I was going for the big payday, and it could still happen. I believe I own a bigger % of the Company now than before the split, and my average is much lower that it was, so I could still make out. But the bottom line is, I owned a $hitload of mnkd, (for me anyway), @ 2.00/Share, on June 27 2014, I could’ve, and should’ve sold for a substantial profit, and then could’ve bought back in after all the smoke cleared and maybe pulled the same again. Oh hindsight is such a buzzkill !! No one to blame but me,, sure, they should run the Company in a manner that enhances shareholder value, and especially shareholders morale !! Transparency is a must, but the buy and sell trigger is all me. Ive learned many lessons that will serve me well from this mnkd journey, but not selling in 2014 is 1 mistake I wish was never made. Good Luck Everybody ✌🏻😎 There was sooo many indicators in hindsight that investors (and myself) ignored. 1. We disliked the original Afrezza partnership agreement terms 2. We lost Al, the driving force behind Afrezza 3. Reputable analysts represented by peons on CC’s.. then not even that. 4. Insiders selling 5. The Afrezza partner walked way 6. Management turnovers 7. Dilution, dilution, dilution At every point, we rationalized the negatives. Some of them we even rationalized into positives... I definitely learned something. I also learned that personally CEO’s lie better than I can detect... One thing I read, that I wrote off is “interesting” at the time, but pops back into my mind these days. ***The CEO of Fidelity doesn’t own stocks. He owns Funds... that’s pretty telling on the “smart” way to invest.
|
|
|
Post by seanismorris on May 12, 2019 12:55:38 GMT -5
1 big disagreement with the previous poster. A niche drug is one that everyone knows about but only a few people need. And some niche drugs still make a lot of money. Afrezza isn't a niche drug, it is an unknown drug. We are using different definitions... not a big deal. I’d consider 5% of the mealtime insulin market niche. Management called Afrezza a “premium” product on the last call. That’s probably referring to the price of Afrezza. Sometimes niche products can be highly profitable, but not this time... I’m going to bang my head against “if only Afrezza had price parity” forever in how we got to this point. ............ Definition “A niche market is the subset of the market on which a specific product is focused. The market niche defines the product features aimed at satisfying specific market needs, as well as the price range, production quality and the demographics that it is intended to target. It is also a small market segment.”
|
|